Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2014, Article ID 350262, 7 pages
Research Article

Indicators of Psychiatric Disorders in Different Oncology Specialties: A Prevalence Study

1Fundação Pio XII, Hospital de Câncer de Barretos, Rua Antenor Antonio Vilela 1331, 14780-000 Barretos, SP, Brazil
2Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 14048-900 Ribeirão Preto, SP, Brazil

Received 21 December 2013; Revised 28 February 2014; Accepted 20 March 2014; Published 14 April 2014

Academic Editor: Richard T. Penson

Copyright © 2014 Manuela Polidoro Lima and Flávia L. Osório. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Objective. This study evaluated the prevalence of various indicators of psychiatric disorders in Brazilian outpatients with cancer and assessed possible associations with sociodemographic indicators. Materials and Methods. A total of 1,385 patients were evaluated using the following instruments: Patient Health Questionnaire-4 (PHQ-4), Generalized Anxiety Disorder (GAD-7), Fagerström Test for Nicotine Dependence (FTND), and Fast Alcohol Screening Test (FAST). Results. The sample was composed of both genders with a slight predominance of women (55.8%), subjects with incomplete/completed elementary school (59%), married (67.4%), with children (94%), not active from a labor viewpoint (61.6%), and following some type of religion (79.5%). The prevalence of anxiety for the total sample varied between 21.5 and 27.4%. The prevalence of depression was 21.1%, tobacco abuse/dependence was 40.2%, and alcohol was 20.3%. Women had significantly higher levels of anxiety and depression than men. Men had higher levels of substance abuse/dependence indicators than women. Conclusion. These results are consistent with the literature, which attests to the high prevalence of psychiatric disorder indicators in cancer patients, especially compared to the general population.